U.S. Food and Drug Administration Commissioner Dr. Scott Gottlieb’s impending departure may push back long-awaited regulations on hemp and CBD, according to experts involved in those industries.

Rick Weissman, the president of hemp products maker High Falls Extracts, said Gottlieb, who announced Tuesday he will leave the FDA at the end of the month, supported hemp and CBD regulatory efforts.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]